Carbohydrate Metabolism Deficiency (NGS Panel and Copy Number Analysis + mtDNA) MNG Laboratories (Medical Neurogenetics, LLC.)
United States | 10 | 52 | - C Sequence analysis of the entire coding region
|
G6PC Prenatal Sequence Analysis (GeneAware) (Prenatal Sequence Analysis) Baylor Genetics
United States | 1 | 1 | - E Sequence analysis of select exons
|
G6PC Sequence Analysis (Familial Mutation/Variant Analysis) Baylor Genetics
United States | 1 | 1 | - E Sequence analysis of select exons
|
Super Panel Plus NxGen MDx
United States | 116 | 117 | - D Deletion/duplication analysis
- E Sequence analysis of select exons
- C Sequence analysis of the entire coding region
- T Targeted variant analysis
|
Universal Panel Plus NxGen MDx
United States | 21 | 22 | - D Deletion/duplication analysis
- E Sequence analysis of select exons
- C Sequence analysis of the entire coding region
- T Targeted variant analysis
|
Ashkenazi Jewish Panel NxGen MDx
United States | 20 | 21 | - D Deletion/duplication analysis
- E Sequence analysis of select exons
- C Sequence analysis of the entire coding region
|
Super Panel 113 NxGen MDx
United States | 113 | 115 | - D Deletion/duplication analysis
- E Sequence analysis of select exons
- C Sequence analysis of the entire coding region
- T Targeted variant analysis
|
Horizon 106 plus TSE Natera, Inc.
United States | 103 | 107 | - E Enzyme assay
- E Sequence analysis of select exons
- C Sequence analysis of the entire coding region
- T Targeted variant analysis
|
Horizon 27 Natera, Inc.
United States | 28 | 28 | - E Sequence analysis of select exons
- C Sequence analysis of the entire coding region
- T Targeted variant analysis
|
Horizon 106 Natera, Inc.
United States | 103 | 106 | - E Sequence analysis of select exons
- C Sequence analysis of the entire coding region
- T Targeted variant analysis
|
Horizon 27 plus TSE Natera, Inc.
United States | 28 | 29 | - E Enzyme assay
- E Sequence analysis of select exons
- C Sequence analysis of the entire coding region
- T Targeted variant analysis
|
Horizon 274 Plus TSE Natera, Inc.
United States | 265 | 275 | - E Enzyme assay
- E Sequence analysis of select exons
- C Sequence analysis of the entire coding region
- T Targeted variant analysis
|
Horizon 274 Natera, Inc.
United States | 265 | 274 | - E Sequence analysis of select exons
- C Sequence analysis of the entire coding region
- T Targeted variant analysis
|
Horizon 137 plus TSE Natera, Inc.
United States | 135 | 138 | - E Enzyme assay
- E Sequence analysis of select exons
- C Sequence analysis of the entire coding region
- T Targeted variant analysis
|
Horizon 137 Natera, Inc.
United States | 135 | 137 | - E Sequence analysis of select exons
- C Sequence analysis of the entire coding region
- T Targeted variant analysis
|
Horizon 274 Natera, Inc.
United States | 265 | 274 | - E Sequence analysis of select exons
- C Sequence analysis of the entire coding region
- T Targeted variant analysis
|
Mitochondrial Panel, Nuclear genes CNH Molecular Diagnostics Laboratory Childrens National Hospital
United States | 145 | 134 | - C Sequence analysis of the entire coding region
|
Ashkenazi Jewish Diseases Asper Biogene Asper Biogene LLC
Estonia | 43 | 37 | - C Sequence analysis of the entire coding region
- T Targeted variant analysis
|
Foresight Myriad Genetics, Inc.
United States | 112 | 110 | - D Deletion/duplication analysis
- C Sequence analysis of the entire coding region
- T Targeted variant analysis
|
Ketotic Hypoglycemia panel Al Jalila Children's Genomics Center Al Jalila Childrens Speciality Hospital
United Arab Emirates | 10 | 10 | - C Sequence analysis of the entire coding region
|
